HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

lupeol linoleate

Networked: 13 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Triterpenes: 2493
      - Pentacyclic Triterpenes: 108
        Lupanes: 28
        lupeol linoleate: 13
Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Essential Fatty Acids: 734
      - Linoleic Acids: 78
        lupeol linoleate: 13
    - Omega-6 Fatty Acids: 555
      - Linoleic Acids: 78
        lupeol linoleate: 13

Experts

1.	Varalakshmi, Palaninathan: 6 articles (09/2008 - 09/2002)
2.	Varalakshmi, P: 4 articles (10/2008 - 06/2001)
3.	Mythili, Yenjerla: 3 articles (11/2006 - 01/2006)
4.	Selvakumar, Elangovan: 3 articles (11/2006 - 01/2006)
5.	Sudharsan, Periyasamy Thandavan: 3 articles (11/2006 - 01/2006)
6.	Sudhahar, V: 2 articles (10/2008 - 01/2007)
7.	Sudhahar, Varatharajan: 2 articles (09/2008 - 02/2006)
8.	Ashok Kumar, S: 1 article (10/2008)
9.	Sujatha, V: 1 article (10/2008)
10.	Veena, Coothan Kandaswamy: 1 article (09/2008)

Related Diseases

1.	Urolithiasis 09/01/2002 - "Investigations were carried out to evaluate the efficacy of the pentacyclic triterpene, lupeol and its ester, lupeol linoleate, against calcium oxalate urolithiasis in rats. "
2.	Hyperoxaluria (Oxaluria) 09/01/2008 - "Antiurolithic effect of lupeol and lupeol linoleate in experimental hyperoxaluria." 09/01/2008 - "The present study was undertaken to explore the efficiency of the pentacyclic triterpene lupeol (1) and its ester derivative, lupeol linoleate (2), in experimental hyperoxaluria. "
3.	Body Weight (Weight, Body) 03/01/1998 - "Lupeol and lupeol linoleate were administered orally at the dose level of 50 mg kg-1 body weight daily for 8 days, from the 11th to 18th day postadjuvantly. " 11/01/2006 - "CP treated groups V and VI received lupeol and lupeol linoleate (50 mg/kg body weight) respectively, dissolved in olive oil for 10 days by oral gavage. " 02/01/2006 - "Lupeol (50 mg/kg body weight for 10 days orally) and its ester, lupeol linoleate (50 mg/kg body weight for 10 days orally) showed reversal of the above alterations induced by CP. " 01/01/2006 - "CP-treated groups V and VI received lupeol and lupeol linoleate (50 mg/kg body weight), respectively, dissolved in olive oil for 10 days by oral gavage. " 06/01/2005 - "The cardioprotective effects of lupeol (50 mg/kg body weight for 10 days orally) and its ester, lupeol linoleate (50 mg/kg body weight for 10 days orally) were evident from the significant reversal of the above alterations induced by CP. "
4.	Hypercholesterolemia 10/01/2008 - "Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage." 02/16/2006 - "Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia." 01/01/2007 - "Mitigating role of lupeol and lupeol linoleate on hepatic lipemic-oxidative injury and lipoprotein peroxidation in experimental hypercholesterolemia."
5.	Experimental Arthritis 06/01/2001 - "Lupeol, lupeol linoleate and indomethacin showed a reduction in paw swelling by 39, 58 and 35%, respectively, in adjuvant arthritis. " 04/01/1999 - "The effects of lupeol and lupeol linoleate on the development of complement in adjuvant arthritis in rats were studied and compared with those of indomethacin. "

Related Drugs and Biologics

1.	lupeol
2.	Esters
3.	Triterpenes
4.	Calcium Oxalate
5.	Indomethacin (Indometacin)
6.	Olive Oil
7.	Lipoproteins (Lipoprotein)
8.	Enzymes
9.	Complement System Proteins (Complement)
10.	Collagen